MAIA
MAIA Biotechnology Inc.
NYSE MKT: MAIA · HEALTHCARE · BIOTECHNOLOGY
$1.30
+4.00% today
Updated 2026-04-29
Market cap
$75.23M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.70
Dividend yield
—
52W range
$1 – $3
Volume
0.9M
MAIA Biotechnology Inc. (MAIA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-745.00%
ROA
-152.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-6.49M | — | — | — |
| 2020 | $0.00 | $-6.64M | — | — | — |
| 2021 | $0.00 | $-12.50M | — | — | — |
| 2022 | $0.00 | $-15.77M | — | — | — |
| 2023 | $0.00 | $-19.77M | — | — | — |
| 2024 | $0.00 | $-23.25M | — | — | — |
| 2025 | $0.00 | $-22.40M | — | — | — |